newsfilter
← Latest News
GlobeNewswire·

Checkmate Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update

Alan Fuhrman appointed interim President and CEO Clinical trials with vidutolimod (CMP-001) in melanoma, head and neck cancer indications ongoing Clinical data readouts anticipated in 2022 CAMBRIDGE, Mass., Nov. 12, 2021 (GLOBE NEW